CMPS — COMPASS Pathways Share News
0.000.00%
Last trade - 00:00Compass Pathways PLC expected to post a loss of 57 cents a share - Earnings Preview
Brief: Compass Pathways PLC Files For Mixed Shelf Of Up To $400 mln
Compass Pathways PLC reports results for the quarter ended in June - Earnings Summary
Brief: COMPASS Pathways Q2 EPS USD -0.56
Compass Pathways PLC expected to post a loss of 53 cents a share - Earnings Preview
Brief: Compass Pathways Appoints Lori Englebert As Chief Commercial Officer
U.S. STOCKS ON THE MOVE-Sigma Lithium, U.S Gold , Ballard Power
Compass Pathways PLC reports results for the quarter ended in March - Earnings Summary
Compass Pathways gains on mid-stage data for experimental PTSD treatment
Brief: Compass Pathways Announces Durable Improvement In Symptoms Through 12 Weeks In Open-Label Phase 2 Study Of Comp360 Psilocybin In Post-Traumatic Stress Disorder
Brief: COMPASS Pathways Q1 EPS USD -0.55
US FDA panel to discuss first psychedelic-assisted PTSD treatment next month (updated)
Brief: Compass Pathways And Journey Clinical Establish Research Collaboration Agreement
Compass Pathways PLC reports results for the quarter ended in December - Earnings Summary
Brief: COMPASS Pathways Q4 EPS USD -0.53
Compass Pathways PLC expected to post a loss of 33 cents a share - Earnings Preview
Compass Pathways PLC expected to post a loss of 33 cents a share - Earnings Preview
Brief: Compass Pathways And Greenbrook Tms Enter Into Three-Year Research Collaboration Agreement
Brief: Paradigm Biocapital Advisors Reports 5.4% Passive Stake In Compass Pathways PLC As Of December 20, 2023- SEC Filing